| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |